Today: 1 July 2026
Browse Category

NASDAQ:BCRX 14 October 2025 - 2 March 2026

Astria Therapeutics Stock Skyrockets 53% After $700M Buyout – What’s Next?

Astria Therapeutics Stock Skyrockets 53% After $700M Buyout – What’s Next?

On Oct. 14, 2025, Astria was swept into the headlines by a surprise $700+ million takeover. BioCryst Pharmaceuticals announced a definitive merger agreement to acquire Astria for $8.55 in cash plus 0.59 shares of BioCryst stock per Astria share marketscreener.com reuters.com. This values Astria at roughly $920M equity and $700M enterprise stocktitan.net. The Boards of both companies approved the deal, which is expected to close in Q1 2026 stocktitan.net. Astria CEO Jill Milne will join BioCryst’s board post-merger stocktitan.net. Market reaction: News of the deal caused Astria’s stock to jump sharply. Reuters reported ATXS shares rose over 40% in pre-market trading on Oct. 14 reuters.com, and ChartMill noted a 44.27% pre-market gain to $12.22 chartmill.com. On Oct. 13 close ATXS was $8.47 investing.com; as of Oct. 14 morning it was about $11.90 investing.com. Trading in ATXS was briefly halted on Oct. 14 due to pending news marketbeat.com.
14 October 2025
···

Stock Market Today

  • Geiger Counter Ltd Buys Back 19,069 Shares at 63.95p Each
    July 1, 2026, 4:59 AM EDT. Geiger Counter Ltd repurchased 19,069 ordinary shares on June 30, 2026, paying an average of 63.95 pence per share. That price is about a 7% discount to fully diluted value. The company said the shares go into Treasury as part of an ongoing program. Since March 11, 2026, the group has repurchased 7,392,222 shares under the plan. After this buyback, Geiger Counter has 173,641,396 ordinary shares outstanding, with 118,410,966 voting shares and 55,230,430 in Treasury. The company said the buybacks are meant to keep capital structure and shareholder value on track.
Go toTop